Setting the Record Straight on Mental Health & Texas
This article was originally published by the Texas Tribune on November 7, 2022 and is authored by Meadows Institute President and CEO, Andy Keller, PhD. Ongoing criticisms that Texas is lagging behind the rest of…
School shooters and mental health. What is Texas actually doing?
This article was originally published by the Dallas Morning News on June 5, 2022. The day after a gunman slaughtered 19 fourth-graders and two teachers at their elementary school in Uvalde, the father of one…
U.S. Senate Committee on Health, Education, Labor & Pensions
SUMMARY - During his invited testimony, President and CEO Andy Keller, PhD, discussed the mental health impacts of COVID-19 and how lessons learned in Texas can be used nationally to address mental health and...
Each year, about 3,000 Texas adolescents and young adults ages 12-35 experience a first episode of psychosis (FEP).Many have access to health insurance through their parents (up to age 26), Medicaid or CHIP, but they…
Each year, about 3,000 Texas adolescents and young adults ages 12-35 experience a first episode of psychosis (FEP).Many have access to health insurance through their parents (up to age 26), Medicaid or CHIP, but they do not typically receive care and treatment until five years after first onset of psychosis.
Studies show that the longer treatment is delayed, the worse the outcome, both for the individual and for society.While most people who experience psychosis are not violent, they are much more likely to be violent or become entangled in our criminal justice system when their conditions go untreated.
In June 2022, Meadows Mental Health Policy Institute issued a revised report which explores the basics of coordinated specialty care (CSC) – a team-based approach to provide assertive and intensive treatment as early after the initial psychosis as possible. It covers demographics, detection, screening and treatment in practice and provides and overview of the cost and impact of untreated psychosis in Texas.